Leukocyte immunoglobulin‐like receptor A3 is increased in IBD patients and functions as an anti‐inflammatory modulator

Growing evidence shows that a homozygous 6·7‐kb deletion of the novel anti‐inflammatory molecule leukocyte immunoglobulin‐like receptor A3 (LILRA3) is associated with many autoimmune disorders. However, its effects on pathogenesis of inflammatory bowel disease (IBD) have yet not been clarified. LILR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, X., Liu, F., Ma, J., Chang, Y., Xiang, L., Shen, X., Zhou, F., Zhao, Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806419/
https://www.ncbi.nlm.nih.gov/pubmed/33006756
http://dx.doi.org/10.1111/cei.13529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806419/
https://www.ncbi.nlm.nih.gov/pubmed/33006756
http://dx.doi.org/10.1111/cei.13529

Ejemplares similares